Chlorpromazine Induced Cataract in a female patient: A Case Report

Authors

  • Nidhi Rajeshwori Thapa Department of Psychiatry, Nepal Medical College and Teaching Hospital, Kathmandu, Nepal
  • Deepika Karki Nepal Medical College and Teaching Hospital, Kathmandu, Nepal
  • Asim Shrestha Nepal Medical College and Teaching Hospital, Kathmandu, Nepal
  • Pradip Man Singh Department of Psychiatry, Nepal Medical College and Teaching Hospital, Kathmandu, Nepal

DOI:

https://doi.org/10.3126/jpan.v11i2.57688

Keywords:

cataract, chlorpromazine, schizophrenia, antipsychotic agents

Abstract

Tablet Chlorpromazine is a commonly used, affordable antipsychotic in developing countries. Chlorpromazine induced cataract and corneal pigmentation was first described by Greiner & Berry in 1964 but in the context of Nepal, there is no available literature or cases reported to date. Despite having a myriad of side effects, it is still used frequently in developing countries due to its cost-effectiveness. In this light, we report a case of a 43-year-old female with a diagnosis of Schizophrenia who had been treated with Tab. Chlorpromazine for 25 years. She lost to follow-up and presented at the OPD with cataract in bilateral eyes.  

Downloads

Download data is not yet available.
Abstract
56
PDF
76
Cover JPAN

Downloads

Published

2022-12-31

How to Cite

Thapa, N. R., Karki, D., Shrestha, A., & Singh, P. M. (2022). Chlorpromazine Induced Cataract in a female patient: A Case Report. Journal of Psychiatrists' Association of Nepal, 11(2), 49–51. https://doi.org/10.3126/jpan.v11i2.57688

Issue

Vol. 11 No. 2 (2022)

Section

Case Report

License

Copyright (c) 2022 Journal of Psychiatrists' Association of Nepal

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.